- Conditions
- Epidermolysis Bullosa Simplex
- Interventions
- 5% TolaSure Topical Gel, Topical Placebo Gel
- Drug
- Lead sponsor
- BioMendics, LLC
- Industry
- Eligibility
- 4 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 2
- States / cities
- Palo Alto, California • Chicago, Illinois
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Epidermolysis Bullosa Simplex, Epidermolysis Bullosa Simplex Kobner, Weber-Cockayne Syndrome
- Interventions
- Sirolimus, 2%, Vehicle
- Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 4 Years and older
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2021
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Generalized Epidermolysis Bullosa Simplex
- Interventions
- AC-203, Vehicle
- Drug
- Lead sponsor
- TWi Biotechnology, Inc.
- Industry
- Eligibility
- 6 Months and older
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 7
- States / cities
- Rancho Santa Margarita, California • Stanford, California • Aurora, Colorado + 4 more